// App-Quantinova.ai

P4-21-23 : A retrospective evaluation of cardiovascular recovery and oncologic outcomes associated with interrupted and continuous adjuvant trastuzumab in the setting of mild left ventricular dysfunction

Researchers

Presenter

  • JD Gibson

Principal Investigators

  • RJR Yao

  • MK Davis

  • CE Simmons

Medical Centers

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • Vancouver Fraser Medical Program, University of British Columbia, Vancouver, BC, Canada

  • The University of British Columbia, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Left ventricular dysfunction

  • Congestive heart failure

  • Breast cancer

  • Solid malignancies

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • Trastuzumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved